Potential Medicare Savings From Generic Substitution and Therapeutic Interchange of ACE Inhibitors and Angiotensin-II-Receptor Blockers

JAMA Intern Med. 2019 Aug 5;179(12):1712-1714. doi: 10.1001/jamainternmed.2019.3107. Online ahead of print.

Abstract

This economic evaluation study estimates the potential Medicare savings from generic substitution and therapeutic interchange of brand-name hypertension medications.